Frozen shoulder trial: At GP practice and community setting (ACCorD)
- Conditions
- Frozen shoulderMusculoskeletal DiseasesAdhesive capsulitis of shoulder
- Registration Number
- ISRCTN14209869
- Lead Sponsor
- Barts Health NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 54
Adults with frozen shoulder, defined as:
1. Aged 18 years and older
2. Loss of passive external rotation of at least 50% compared with the contralateral side
3. Presence of symptoms for at least 4 weeks
4. Plain radiographs demonstrating the absence of glenohumeral osteoarthritis or other pathology
1. Recurrent ipsilateral frozen shoulder
2. Presentation following breast cancer or local radiotherapy
3. Known rotator cuff tear
4. Long-term systemic corticosteroid use, or previous ipsilateral shoulder CSI within 12 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The rate of eligible participants presenting to the MSK hubs (Screening logs)<br>2. The proportion of eligible participants that clinicians are willing to recruit (Baseline visit 1, questionnaires)<br>3. The proportion of eligible participants that are randomised (Baseline visit 1/Intervention visit 2, questionnaires)<br>4. Adherence to the study protocol and attrition at 6 months (All visits (1-6), questionnaires)<br>5. Data completeness using traditional clinical reporting forms and routine data sources.
- Secondary Outcome Measures
Name Time Method 1. Upper limb function will be assessed using the Oxford Shoulder Score (OSS) (Baseline visit 2, Follow up at visit 3-6; questionnaires)<br>2. Quality of life will be assessed using the Euroquol (EQ-5D-5L) (Baseline visit 2, Follow up at visit 3-6; questionnaires)<br>3. Upper limb range of motion (Baseline visit 2, Follow up at visit 3-6; Face to face study visit measurement and also from photos of upper limb submitted by participants)<br>4. Resource use (Baseline visit 2, Follow up at visit 3-6; questionnaires)